Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
Radiofrequency ablation is used to treat metastatic colorectal cancer. In this study, the authors show that incomplete ablation of tumours results in metastases and show in mouse models that the chemokine CCL2 recruits myeloid cells to the partially ablated tumours, which can block T cell function.
Saved in:
Main Authors: | Liangrong Shi, Junjun Wang, Nianhua Ding, Yi Zhang, Yibei Zhu, Shunli Dong, Xiaohui Wang, Changli Peng, Chunhui Zhou, Ledu Zhou, Xiaodong Li, Hongbing Shi, Wei Wu, Xueyin Long, Changping Wu, Weihua Liao |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/7ee06799e14541969149a6f48d4cd21b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
by: Bin Chai, et al.
Published: (2021) -
Radiofrequency ablation of the lateral palatal space for snoring
by: B. Tucker Woodson, et al.
Published: (2017) -
Optical signatures of radiofrequency ablation in biological tissues
by: Pranav Lanka, et al.
Published: (2021) -
Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
by: Huiyang Wang, et al.
Published: (2021) -
Predictors of Recurrence of AF in Patients After Radiofrequency Ablation
by: Iskren Garvanski, et al.
Published: (2019)